protein

Recombinant Human IL-20R alpha Fc Chimera Protein, CF

1176-IR-050

50 ug

432 USD

1176-IR-050

Recombinant Human IL-20R alpha Fc Chimera Protein, CF

50 ug

The Recombinant Human IL-20R alpha Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human IL-20R alpha Fc Chimera Protein, CF has been validated for the following applications: Binding Activity.

IL-20R alpha

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain

Human

70-85 kDa, reducing conditions

52 kDa (monomer)

IL20RA

Measured by its binding ability in a functional ELISA. Immobilized rhIL-20 Ra/Fc Chimera at 1 ╡g/mL (100 ╡L/well) can bind rhIL-26 with a linear range of 0.3-20 ng/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

Q9UHF4

Binding Activity

Mouse myeloma cell line, NS0-derived human IL-20 R alpha protein Human IL-20 R alpha (Val30 - Lys250) Accession # Q9UHF4 DIEGRMD Human IgG1 (Pro100 - Lys330) N-terminus C-terminus

NS0

432 USD

class II cytokine receptor ZCYTOR7, CRF2-8, Cytokine receptor class-II member 8, Cytokine receptor family 2 member 8, FLJ40993, IL-20 R alpha, IL20R alpha, IL-20R1, IL-20R1IL-20 receptor subunit alpha, IL20RA, IL-20RA, IL-20R-alpha, interleukin 20 receptor, alpha, interleukin-20 receptor I, interleukin-20 receptor subunit alpha, ZcytoR7

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.